Effect of inhibitors and respiratory factors on the growth of respiratory syncytial (RS) virus in Hep-2 cell cultures.
D000814:Aniline Compounds / Q000494:pharmacology*; D002951:Citrates / Q000494:pharmacology*; D002952:Citric Acid Cycle; D046508:Culture Techniques; D004140:Dinitrophenols / Q000494:pharmacology*; D005463:Fluoroacetates / Q000494:pharmacology*; D005650:Fumarates / Q000494:pharmacology*; D006019:Glycolysis; D007461:Iodoacetates / Q000494:pharmacology*; D008314:Malonates / Q000494:pharmacology*; D012136:Respiratory Syncytial Viruses / Q000187:drug effects* / Q000378:metabolism*; D013386:Succinates / Q000494:pharmacology*; D014776:Virus Cultivation
D000814:Aniline Compounds; D002951:Citrates; D004140:Dinitrophenols; D005463:Fluoroacetates; D005650:Fumarates; D007461:Iodoacetates; D008314:Malonates; D013386:Succinates